News
Engaging all stakeholders in the process of establishing a global MI service is key to its overall success. Each ...
Using microneedle arrays developed at Carnegie Melon, microdosed with a known chemotherapeutic agent delivered directly to ...
The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...
A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles ...
The UK government has revealed a plan to open a biosecurity facility in Harlow, Essex, to help protect the country from ...
The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...
The 2nd Hit ID Summit is your go-to hub for drug hunters looking to crack through targets and uncover quality leads. Join 60+ ...
An antibody being developed by AstraZeneca for the treatment of light chain (AL) amyloidosis has failed to move the needle in ...
EVERSANA has launched a new pharmacovigilance (PV) platform that answers the need to apply advanced data analytics and ...
The plan – backed with a £2 billion ($2.68 billion) funding pledge – revolves around three overarching objectives; namely, ...
Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...
At ASCO 2025, Johnson & Johnson contributed more than 70 abstracts, reflecting the depth of their oncology portfolio, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results